Your doctor better be following up with these to see which may be useful for you. And if your doctor was any good they would be participating in these trials. How the hell else do you think stroke drugs are going to be evaluated?
http://www.lexology.com/library/detail.aspx?g=b66d5428-b2b4-4593-9bc4-e082f4309d45
According to a new Pharmaceutical Research and Manufacturers of America (PhRMA) report,
U.S. biopharmaceutical companies have 215 medicines under development
for the treatment of heart disease and stroke. The medicines, which are
currently either in human clinical trials or undergoing U.S. Food and
Drug Administration review, aim to treat or prevent these two leading
causes of death in the United States by addressing heart failure, lipid
disorders, stroke, and hypertension. PhRMA President and CEO John
Castellani noted that many of these pipeline drugs use cutting-edge
technologies including gene therapy and genetic engineering. He said,
“These promising new approaches offer great hope to better prevent and
treat heart diseases. They also hold the potential of helping to control
costs within our healthcare system, as reflected in a growing body of
evidence showing that medicines— including those for heart disease—can
help control overall healthcare costs.” See PhRMA Press Release, June 12, 2013.
No comments:
Post a Comment